A citation-based method for searching scientific literature


List of co-cited articles
17 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?
Lorna McWilliams, Victoria G Woof, Louise S Donnelly, Anthony Howell, D Gareth Evans, David P French. BMC Cancer 2021
6
100

Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada.
Cynthia Mbuya Bienge, Nora Pashayan, Jennifer D Brooks, Michel Dorval, Jocelyne Chiquette, Laurence Eloy, Annie Turgeon, Laurence Lambert-Côté, Jean-Sébastien Paquette, Emmanuelle Lévesque,[...]. J Pers Med 2021
12
100

Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey.
Alex Ghanouni, Saskia C Sanderson, Nora Pashayan, Cristina Renzi, Christian von Wagner, Jo Waller. J Med Screen 2020
18
100

Acceptability of risk-stratified population screening across cancer types: Qualitative interviews with the Australian public.
Kate Dunlop, Nicole M Rankin, Amelia K Smit, Zofia Salgado, Ainsley J Newson, Louise Keogh, Anne E Cust. Health Expect 2021
6
66

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
Nora Pashayan, Steve Morris, Fiona J Gilbert, Paul D P Pharoah. JAMA Oncol 2018
134
66

Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
D Gareth R Evans, Elaine F Harkness, Adam R Brentnall, Elke M van Veen, Susan M Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J Howell,[...]. Breast Cancer Res Treat 2019
33
66

Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders' views on a low-risk breast screening pathway.
Lorna McWilliams, Victoria G Woof, Louise S Donnelly, Anthony Howell, D Gareth Evans, David P French. BMC Cancer 2020
15
66

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
711
66

Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
D Gareth R Evans, Elke M van Veen, Elaine F Harkness, Adam R Brentnall, Susan M Astley, Helen Byers, Emma R Woodward, Sarah Sampson, Jake Southworth, Sacha J Howell,[...]. Genet Med 2022
3
66

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
79
66

Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort.
Adam R Brentnall, Elaine F Harkness, Susan M Astley, Louise S Donnelly, Paula Stavrinos, Sarah Sampson, Lynne Fox, Jamie C Sergeant, Michelle N Harvie, Mary Wilson,[...]. Breast Cancer Res 2015
118
66

What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
David P French, Susan Astley, Adam R Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Gorman, Elaine F Harkness, Fiona Harrison, Michelle Harvie,[...]. BMC Cancer 2020
21
66

Breast Cancer Risk Assessment and Primary Prevention Advice in Primary Care: A Systematic Review of Provider Attitudes and Routine Behaviours.
Sarah Bellhouse, Rhiannon E Hawkes, Sacha J Howell, Louise Gorman, David P French. Cancers (Basel) 2021
7
66

Breast cancer risk feedback to women in the UK NHS breast screening population.
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
51
66

The current status of risk-stratified breast screening.
Ash Kieran Clift, David Dodwell, Simon Lord, Stavros Petrou, Sir Michael Brady, Gary S Collins, Julia Hippisley-Cox. Br J Cancer 2022
10
66

The introduction of risk stratified screening into the NHS breast screening Programme: views from British-Pakistani women.
Victoria G Woof, Helen Ruane, David P French, Fiona Ulph, Nadeem Qureshi, Nasaim Khan, D Gareth Evans, Louise S Donnelly. BMC Cancer 2020
9
66

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
511
66

Adjusting the frequency of mammography screening on the basis of genetic risk: Attitudes among women in the UK.
Susanne F Meisel, Nora Pashayan, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. Breast 2015
35
33

Preferences for cancer investigation: a vignette-based study of primary-care attendees.
Jonathan Banks, Sandra Hollinghurst, Lin Bigwood, Tim J Peters, Fiona M Walter, Willie Hamilton. Lancet Oncol 2014
82
33

Screening: A risk-based framework to decide who benefits from screening.
Philip E Castle, Hormuzd A Katki. Nat Rev Clin Oncol 2016
8
33

An international measure of awareness and beliefs about cancer: development and testing of the ABC.
Alice E Simon, Lindsay J L Forbes, David Boniface, Fiona Warburton, Kate E Brain, Anita Dessaix, Michael Donnelly, Kerry Haynes, Line Hvidberg, Magdalena Lagerlund,[...]. BMJ Open 2012
69
33


Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.
Pamela M Marcus, Nora Pashayan, Timothy R Church, V Paul Doria-Rose, Michael K Gould, Rebecca A Hubbard, Michael Marrone, Diana L Miglioretti, Paul D Pharoah, Paul F Pinsky,[...]. Cancer Epidemiol Biomarkers Prev 2016
37
33

Population-based screening for cancer: hope and hype.
Yiwey Shieh, Martin Eklund, George F Sawaya, William C Black, Barnett S Kramer, Laura J Esserman. Nat Rev Clin Oncol 2016
63
33


CJCheck Stage 1: development and testing of a checklist for reporting community juries - Delphi process and analysis of studies published in 1996-2015.
Rae Thomas, Rebecca Sims, Chris Degeling, Jackie M Street, Stacy M Carter, Lucie Rychetnik, Jennifer A Whitty, Andrew Wilson, Paul Ward, Paul Glasziou. Health Expect 2017
18
33

The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment.
Juliet A Usher-Smith, Katie M Mills, Christiane Riedinger, Catherine L Saunders, Lise M Helsingen, Lyubov Lytvyn, Maaike Buskermolen, Iris Lansdorp-Vogelaar, Michael Bretthauer, Gordon Guyatt,[...]. PLoS One 2021
2
50

Equality and equity in medical screening: what is fair?
Peter Sasieni. Lancet Gastroenterol Hepatol 2019
2
50

Ethical, legal, and social implications of incorporating genomic information into electronic health records.
Ribhi Hazin, Kyle B Brothers, Bradley A Malin, Barbara A Koenig, Saskia C Sanderson, Mark A Rothstein, Marc S Williams, Ellen W Clayton, Iftikhar J Kullo. Genet Med 2013
62
33

A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening.
Rebecca A Dennison, Rachel A Boscott, Rae Thomas, Simon J Griffin, Hannah Harrison, Stephen D John, Sowmiya A Moorthie, Stephen Morris, Sabrina H Rossi, Grant D Stewart,[...]. Health Expect 2022
2
50

Should women aged 70-74 be invited to participate in screening mammography? A report on two Australian community juries.
Chris Degeling, Alexandra Barratt, Sanchia Aranda, Robin Bell, Jenny Doust, Nehmat Houssami, Jolyn Hersch, Ruben Sakowsky, Vikki Entwistle, Stacy M Carter. BMJ Open 2018
9
33


Trying to "Protect the NHS" in the United Kingdom.
David J Hunter. N Engl J Med 2020
6
33

Public interest in and acceptability of the prospect of risk-stratified screening for breast and prostate cancer.
Marie Koitsalu, Mirjam A G Sprangers, Martin Eklund, Kamila Czene, Per Hall, Henrik Grönberg, Yvonne Brandberg. Acta Oncol 2016
27
33

Patient Attitudes Toward Individualized Recommendations to Stop Low-Value Colorectal Cancer Screening.
Marc S Piper, Jennifer K Maratt, Brian J Zikmund-Fisher, Carmen Lewis, Jane Forman, Sandeep Vijan, Valbona Metko, Sameer D Saini. JAMA Netw Open 2018
21
33

Genetic testing and personalized ovarian cancer screening: a survey of public attitudes.
Susanne F Meisel, Belinda Rahman, Lucy Side, Lindsay Fraser, Sue Gessler, Anne Lanceley, Jane Wardle. BMC Womens Health 2016
21
33

Enhancing citizen engagement in cancer screening through deliberative democracy.
Lucie Rychetnik, Stacy M Carter, Julia Abelson, Hazel Thornton, Alexandra Barratt, Vikki A Entwistle, Geraldine Mackenzie, Glenn Salkeld, Paul Glasziou. J Natl Cancer Inst 2013
44
33

People's willingness to accept overdetection in cancer screening: population survey.
Ann Van den Bruel, Caroline Jones, Yaling Yang, Jason Oke, Paul Hewitson. BMJ 2015
28
33



The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.
Katrina F Brown, Harriet Rumgay, Casey Dunlop, Margaret Ryan, Frances Quartly, Alison Cox, Andrew Deas, Lucy Elliss-Brookes, Anna Gavin, Luke Hounsome,[...]. Br J Cancer 2018
199
33

Population-based, risk-stratified genetic testing for ovarian cancer risk: a focus group study.
S F Meisel, L Side, L Fraser, S Gessler, J Wardle, A Lanceley. Public Health Genomics 2013
23
33

The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis.
Chloe Thomas, Olena Mandrik, Catherine L Saunders, Deborah Thompson, Sophie Whyte, Simon Griffin, Juliet A Usher-Smith. Cancer Prev Res (Phila) 2021
11
33

Public health implications from COGS and potential for risk stratification and screening.
Hilary Burton, Susmita Chowdhury, Tom Dent, Alison Hall, Nora Pashayan, Paul Pharoah. Nat Genet 2013
94
33

A Community Jury on PSA screening: what do well-informed men want the government to do about prostate cancer screening--a qualitative analysis.
Lucie Rychetnik, Jenny Doust, Rae Thomas, Robert Gardiner, Geraldine Mackenzie, Paul Glasziou. BMJ Open 2014
29
33

Consolidated principles for screening based on a systematic review and consensus process.
Mark J Dobrow, Victoria Hagens, Roger Chafe, Terrence Sullivan, Linda Rabeneck. CMAJ 2018
94
33

Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population-based survey.
Juliet A Usher-Smith, Laragh L W Harvey-Kelly, Sabrina H Rossi, Hannah Harrison, Simon J Griffin, Grant D Stewart. Health Expect 2021
6
33

Cancer is a preventable disease that requires major lifestyle changes.
Preetha Anand, Ajaikumar B Kunnumakkara, Chitra Sundaram, Kuzhuvelil B Harikumar, Sheeja T Tharakan, Oiki S Lai, Bokyung Sung, Bharat B Aggarwal. Pharm Res 2008
841
33


Evidence from a BreastScreen cohort does not support a longer inter-screen interval in women who have no conventional risk factors for breast cancer.
Naomi Noguchi, Michael Luke Marinovich, Elizabeth Jane Wylie, Helen Gabriel Lund, Nehmat Houssami. Breast 2022
2
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.